India became the #1 IPO market in the world by volume in 2024. Over 300 companies listed. ₹1.71 lakh crore raised on the mainboard alone. The grey market was buzzing every single week. Your WhatsApp groups were full of “apply karo, 80% GMP hai.” Demat accounts hit record highs. IPO investing became a personality trait. And yet, the average retail investor walked away with almost nothing. Or worse, a loss. ----- First, Let’s Get the Numbers Straight

IPO boom KPI snapshot chart in light theme — *Chart 1: IPO boom snapshot and year-end reality for retail outcomes.*

IPO boom KPI snapshot chart in dark theme — *Chart 1: IPO boom snapshot and year-end reality for retail outcomes.*

2024 had 326 IPOs, 90 on the mainboard (NSE/BSE) and 243 on SME platforms (BSE SME and NSE Emerge). The average mainboard listing gain was 30.1%. SME IPOs averaged a 72% listing day gain. On paper, this looks incredible. But here’s what the headlines didn’t tell you. By year-end 2024, **43% of mainboard IPOs were trading below their issue price.** Not below their listing price, below the price at which the company originally sold shares to the public. So even if you got allotment and held on for a few months, almost half the time you were in the red. And the median listing gain? 15.2%. Not 30%. The average gets pulled up by a handful of outliers, stocks like Vibhor Steel Tubes that listed at +181% and Mamata Machinery at +147%. Remove those, and the picture looks a lot more ordinary. Then 2025 came along and the hangover hit hard. The median listing gain collapsed to **3.8%**. More than half of 2025 IPOs ended the year below their listing price. The party was over, and retail investors were left cleaning up.

Average versus median IPO listing gains and 2025 slowdown chart in light theme — *Chart 2: Average headlines versus median reality, plus the 2025 listing-gain collapse.*

Average versus median IPO listing gains and 2025 slowdown chart in dark theme — *Chart 2: Average headlines versus median reality, plus the 2025 listing-gain collapse.*

----- The Allotment Lottery Nobody Talks About Honestly Here’s the thing that makes me genuinely angry when I see IPO hype content online. Everyone talks about listing gains. Nobody talks about the fact that **most retail investors never even get allotment.** In hot IPOs, the ones with 100x, 200x oversubscription, your probability of getting allotment as a retail investor is somewhere between 5% and 15%. That means for every 100 people applying, 85 to 95 walk away with nothing. Their money was locked for T+6 days, six days where that capital earned zero return, and then returned to their account. Now, the people who do get allotment and sell on listing day? They clean up. The system works perfectly for them. Take Vibhor Steel Tubes: issue price ₹151, listing price ₹425. If you got allotment and sold on day one, you made 181% in six days. On a 1-lot investment of roughly ₹21,000, that’s about ₹38,500 in profit. Fantastic. But here’s the other story, the one nobody’s writing LinkedIn posts about. **Investor B**, didn’t get allotment. Watched the stock surge to ₹425 on listing day. FOMO kicked in. Bought 100 shares in the secondary market at ₹425 (₹42,500 invested). By year-end, the stock was at ₹214. Paper loss: ₹21,100. That’s nearly 50% of their investment gone.

Vibhor Steel Tubes Investor A versus Investor B outcome chart in light theme — *Chart 3: Vibhor Steel Tubes shows how allotment luck and FOMO buying create opposite outcomes.*

Vibhor Steel Tubes Investor A versus Investor B outcome chart in dark theme — *Chart 3: Vibhor Steel Tubes shows how allotment luck and FOMO buying create opposite outcomes.*

Same IPO. Completely opposite outcomes. The difference wasn’t intelligence or research or conviction. It was a lottery. This is the fundamental problem. The listing gain narrative is built on the experience of a small minority who got lucky with allotment. The majority of retail investors who engage with “hot” IPOs are actually buying at the peak in the secondary market, not at the issue price. And they’re paying for it. ----- Oversubscription: The Metric That Means Nothing (And Everything Wrong) Let me address the most misunderstood number in Indian IPO culture: oversubscription. When you see “subscribed 200x,” the internet loses its mind. “200x oversubscribed! This is going to moon!” But what does 200x oversubscription actually tell you? It tells you there was speculative demand. That’s it. It tells you nothing about the company’s fundamentals. Nothing about whether the issue price is fair. Nothing about whether the stock will hold its value post-listing. What it actually tells you is that a lot of people applied because the grey market premium was high, because their broker pushed it, because it was trending, because everyone in the group chat was applying. 200x oversubscription has two direct consequences. First, your allotment probability drops to near-zero. Second, the listing pop becomes almost guaranteed, because all those people who didn’t get allotment now want to buy on listing day, creating artificial demand that inflates the price on day one. And then what? The demand evaporates. The allottees who got shares at issue price start selling into that first-day spike. Institutional investors who got preferential allocations exit. The price starts drifting down. Sometimes it drifts for weeks. Sometimes it falls off a cliff within days. The oversubscription number is a hype metric. It’s become a self-fulfilling prophecy that benefits exactly one group: people who already hold shares at issue price. For everyone else, it’s a trap. ----- The SME IPO Segment: Where It Gets Really Ugly If the mainboard IPO story is “retail investors got a bad deal,” the SME IPO story is “retail investors got played.” In 2024, 243 companies listed on SME platforms. The average listing day gain was 72%, nearly double the 37% average from 2023. The numbers look spectacular. Winsol Engineers listed at +387%. Kay Cee Energy & Infra at +367%. Maxposure at +339%. Medicamen Organics at +306%. And then? Winsol Engineers: down 25% from its listing price within months. Maxposure: down 39% from listing price. Medicamen Organics: down 61% from its listing price, ending the year barely above its issue price. MVK Agro Food Product: listed at a 34% discount to issue price, then fell another 50% from there. Total wipeout: 67% below issue price. This isn’t bad luck. This is a pattern. And SEBI has started noticing. SEBI has been actively flagging concerns about price manipulation in the SME segment. The regulator suspects that some merchant bankers, promoters, and market makers are artificially engineering subscription numbers and listing prices. The playbook looks something like this: create buzz around the IPO, get the subscription numbers inflated, manufacture a massive listing pop, let insiders exit at the peak, and watch the stock collapse once the real market takes over. SEBI’s response in late 2024 was to tighten SME IPO norms, introducing minimum EBITDA requirements (₹1 crore for 2 of the last 3 years) and capping the Offer for Sale (OFS) component at 20% of issue size. This is the regulator essentially admitting that a significant chunk of SME IPOs were structured to benefit promoters and insiders at the expense of public investors. The 300-400% listing gains weren’t organic demand. Many of them were engineered moments. And the retail investor chasing those headlines was the last one in and the first one to get hurt. ----- The Grey Market Premium Problem Let me talk about the GMP, the grey market premium, because it has become the single biggest driver of retail IPO decisions in India, and it absolutely should not be. The GMP is an unofficial, unregulated number that tells you what price people are willing to pay for IPO shares before they list. A high GMP creates excitement. It signals “this IPO is going to pop.” People use it to decide whether to apply, and more critically, whether to buy on listing day. Here’s what the GMP is not: it is not a fundamental indicator. It is not regulated. It cannot be verified. It is, in many documented cases, deliberately inflated by parties who benefit from retail FOMO, the same promoters, brokers, and market makers who want heavy subscription numbers and a strong listing day so they can exit at the peak. A high GMP tells you that hype exists. It does not tell you that value exists. These are very different things. And yet, the GMP has become the primary research tool for a massive chunk of retail IPO investors. “GMP 80%, apply karo.” That’s not investing. That’s gambling on someone else’s hype. ----- Who Actually Wins in the IPO Game? Let me just lay this out plainly, because I think a lot of people have a vague sense that something is wrong but haven’t seen it stated directly. **Promoters and existing shareholders** win. They’re selling shares at a price determined by investment bankers whose job is to price the IPO as high as the market will bear. They raise capital or cash out at peak valuation. Once the IPO is done, their job is done. **Anchor investors** win. These are the large institutional investors who get preferential allocation before the IPO opens, at the issue price. They don’t face the allotment lottery. They get shares guaranteed. Many of them exit on or shortly after listing day. **Investment bankers and merchant bankers** win. They collect fees based on the size of the deal. A bigger issue size, a higher oversubscription, all of it means more fees. They have every incentive to hype the IPO and price it aggressively. **The lucky allotment winner who sells on listing day** wins. This is the retail investor success story that gets shared online. It’s real, but it’s the exception, not the rule. **The FOMO buyer in the secondary market** loses. This is the most common retail experience, and it’s the one that never gets talked about in the IPO hype cycle. The system isn’t broken. It’s working exactly as designed, for the people who designed it. ----- The Broader Picture Nobody Wants to Admit Here’s the uncomfortable truth: India’s IPO boom of 2024 was a phenomenal success story for capital markets. Companies raised record amounts of money. Infrastructure got funded. New businesses got public capital. That’s genuinely good. But “the market did well” and “retail investors did well” are not the same sentence. And in 2024, these two things were confused constantly, deliberately or otherwise. The data is clear. 43% of mainboard IPOs were below issue price by year-end. SME IPOs showed a consistent pattern of spectacular listing gains followed by devastating post-listing collapses. Median listing gains were a fraction of what the headlines suggested. And by 2025, even the listing gains had evaporated, median 3.8%, most IPOs trading below listing price within months. The retail investor who applied for every hot IPO in 2024 and sold on day one, if they were lucky enough to get allotment, did well. Everyone else, the 85-90% who didn’t get allotment and then bought into the FOMO, the people who held their allotted shares expecting more gains, the SME IPO buyers attracted by 300% listing pops, most of them lost money. And the system that created this outcome, the lottery-based allotment, the GMP culture, the oversubscription metric being treated as a quality signal, the SME segment with inadequate oversight, none of it has been fundamentally fixed. SEBI is trying. The tighter SME norms are a step in the right direction. But as long as the IPO process remains structured as a short-term lottery rather than a long-term investment opportunity, retail investors will keep playing a game where the house almost always wins. ----- What Should You Actually Do? I’m not going to tell you to stop participating in IPOs. That would be naive. Some IPOs genuinely create long-term wealth. Bajaj Housing Finance is still above its issue price. Kay Cee Energy held its gains. These aren’t mythical outcomes. But go in with clear eyes. The GMP is noise. Oversubscription is noise. The WhatsApp group is definitely noise. What matters is whether the business is good, whether the issue price is fair relative to its peers, and whether you have a real plan beyond “sell on listing day.” If you’re applying for allotment with the intention of selling on listing day, fine, that’s a legitimate short-term play, and if you get allotment, execute it without emotion. If you’re buying in the secondary market on listing day because you missed allotment and the stock is already up 80%? Stop. You are Investor B in the Vibhor Steel Tubes example. You are buying at the peak of a manufactured moment. The people selling to you got their shares at ₹151. You’re paying ₹425. Ask yourself who is on the right side of that trade. The IPO boom created enormous wealth in 2024. Most of it went to promoters, anchor investors, and lucky allotment winners who sold fast. The retail investor, as usual, was invited to the party just in time to pay the tab.

All writing

Find a thread worth pulling.

Budget 2026: The Middle Class Nightmare